Vista Pharmaceuticals Limited (BOM:524711)

India flag India · Delayed Price · Currency is INR
7.63
+0.36 (4.95%)
At close: May 26, 2026
Market Cap492.42M -38.4%
Revenue (ttm)86.30M -13.5%
Net Income-76.94M
EPS-1.32
Shares Out 61.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,530
Open6.85
Previous Close7.27
Day's Range6.85 - 7.76
52-Week Range5.71 - 12.01
Beta0.02
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About Vista Pharmaceuticals

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. The company was incorporated in 1991 and is based in Hyderabad, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1991
Employees 30
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524711
Full Company Profile

Financial Performance

In fiscal year 2025, Vista Pharmaceuticals's revenue was 100.75 million, a decrease of -2.07% compared to the previous year's 102.88 million. Losses were -46.49 million, 3.03% more than in 2024.

Financial Statements

News

Vista Pharmaceuticals Quarterly report: Q3 2026

Vista Pharmaceuticals has published its Q3 2026 quarterly earnings report on February 13, 2026.

3 months ago - Filings

Vista Pharmaceuticals Quarterly report: Q2 2026

Vista Pharmaceuticals has published its Q2 2026 quarterly earnings report on November 13, 2025.

6 months ago - Filings

Vista Pharmaceuticals Quarterly report: Q1 2026

Vista Pharmaceuticals has published its Q1 2026 quarterly earnings report on August 13, 2025.

10 months ago - Filings

Vista Pharmaceuticals Annual report: Q4 2025

Vista Pharmaceuticals has published its Q4 2025 annual report on May 30, 2025.

1 year ago - Filings

Vista Pharmaceuticals Quarterly report: Q4 2025

Vista Pharmaceuticals has published its Q4 2025 quarterly earnings report on May 30, 2025.

1 year ago - Filings